p.98 抽出テキスト

death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2013; 6: 501-511. PMID: 23498675 733. Nakata T, Nakajima K, Yamashina S, et al. A pooled analysis of multicenter cohort studies of

123I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging 2013; 6: 772-784. PMID: 23845574 734. Nakajima K, Nakata T, Yamada T, et al. A prediction model for 5-year cardiac mortality in patients with chronic heart failure using

123I-metaiodobenzylguanidine imaging. Eur J Nucl Med Mol Imaging 2014; 41: 1673-1682. PMID: 24663289 735. Jacobson AF, Senior R, Cerqueira MD, et al. ADMIRE-HF Investigators. Myocardial iodine- 123 meta-iodobenzylguanidine imaging and cardiac events in heart failure: Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010; 55: 2212-2221. PMID: 20188504 736. Tamaki S, Yamada T, Okuyama Y, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: Results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol 2009; 53: 426-435. PMID: 19179201 737. Akutsu Y, Kaneko K, Kodama Y, et al. The significance of cardiac sympathetic nervous system abnormality in the long-term prognosis of patients with a history of ventricular tachyarrhythmia. J Nucl Med 2009; 50: 61-67. PMID: 19091900 738. Kasama S, Toyama T, Sumino H, et al. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction. J Nucl Med 2008; 49: 907-914. PMID: 18483106